Innospec vs Quaker Chemical
Innospec and Quaker Chemical are similar in size: $1.78bn and $1.89bn of revenue in their latest fiscal years. Quaker Chemical grew faster (2.7% against -3.7%). Innospec kept more of each dollar of sales as profit: a net margin of 6.6% against -0.1%.
| Latest fiscal year | InnospecIOSP, 2025 | Quaker ChemicalKWR, 2025 |
|---|---|---|
| Revenue | $1.78bn | $1.89bn |
| Revenue growth | -3.7% | 2.7% |
| Net income | $117m | −$2.5m |
| Operating margin | 7.3% | — |
| Net margin | 6.6% | -0.1% |
| Return on equity | 9.2% | -0.2% |
| Free cash flow | $88.0m | $80.6m |
| Cash | $293m | $180m |
| Total debt | $0 | $905m |
| Debt to equity | 0.0% | — |
| Dividend per share | $1.71 | $1.99 |
| Dividend yield | — | 1.4% |
| Share buybacks | $23.9m | $41.5m |
| Employees | 2,450 | 4,700 |
| Market value | $2.49bn | $2.61bn |
| Price vs our value range | Within our value range | Within our value range |
| Moat score | 62 (Moderate) | 54 (Moderate) |
| Insider trades, 12 months | 1 buys, 18 sales | 0 buys, 2 sales |